Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Fans report amnesia
Jacky Oh dies at 32
‘Career is over’
New details of death
Farewell to residency
Day without immigrants
Gets restraining order
Judge removes himself
3 dead, 2 missing
Recalls self-disgust
Trans speaker canceled
US-CN influence battle
Journalists to strike
Spelling bee champion
FL LGBTQ+ crowdfunding
Badu's rebirth journey
Exits with an injury
Mortgage rates spike
‘A Poem for Europa’
Payment apps unsafe?
Sued by Ford
'The Office' reboot
Japan birth rate drops
NBA Game 1 triumph
Starliner test delayed
Tropical storm Mawar
4-yr-old fatally shot
Debt ceiling approved
Announce engagement
Tropical depression
Considering Senate bid
Jab at each other
Taken into custody
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
14,600 results
9don MSN
FDA approves prescription nasal spray to reverse opioid overdoses
The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee ...
WTVF1mon
FDA approves first over-the-counter naloxone nasal spray
NASHVILLE, Tenn. (WTVF) — The FDA recently approved an over-the-counter naloxone nasal spray. The medication, known as Narcan, reverses the effects of an opioid overdose. Advocates say it's a ...
Yahoo News9d
US FDA approves Opiant's spray for reversing opioid-related overdoses
The approval comes nearly two months after the U.S. health regulator approved the prescription-free sale of Emergent Biosolutions' Narcan nasal spray, which is a naloxone-based drug used to reverse ...
drugdeliverybusiness9d
FDA approves another nasal spray for treating opioid overdose
The FDA approved Opvee nalmefene hydrochloride nasal spray for the emergency treatment of opioid overdoses from Opiant ...
NBC News3d
FDA approves drug to treat hot flashes and night sweats
The Food and Drug Administration approved on Friday a new nonhormonal medication to treat the hot flashes and night sweats that often plague people during menopause. While not quite as effective ...
Seeking Alpha22d
Emergent BioSolutions: A Turnaround In Sight With OTC Narcan Amidst Ongoing Opioid Crisis
The FDA has approved Emergent's over-the-counter Narcan, a drug to treat opioid overdoses. OTC Narcan can contribute significantly to combatting the escalating opioid crisis in the U.S. The OTC ...
Medscape7d
FDA Approvals
FDA Approves Methylphenidate Patch for Teens With ADHD The FDA has approved an expanded age range for a methylphenidate transdermal system for the treatment of ADHD in adolescents aged 13 to 17 years.
10d
FDA Approves New Nasal Spray to Reverse Opioid Overdoses
It’s not yet clear how the drug will be used differently than naloxone, and some experts see downsides to its longer-acting ...
FOX 10 Phoenix
9d
FDA approves new nasal spray to reverse fentanyl, other opioid overdoses
U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...
EMS1
10d
FDA approves new nasal spray to reverse fentanyl, opioid overdoses
U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...
Too Old to Operate
9d
FDA Approves New Nasal Spray to Reverse Overdoses
The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as Opvee, the spray contains the medication nalmefene hydrochloride and will ...
High Times
8d
FDA Approves Nasal Spray To Reverse Fentanyl Overdoses
The Food and Drug Administration on Monday said that it had given regulatory approval to a nasal spray that has proven ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback